Pittman Scott M. - 15 Nov 2024 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
Director, 10%+ Owner
Signature
/s/ David E. Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
15 Nov 2024
Net transactions value
+$90,417
Form type
4
Filing time
19 Nov 2024, 17:51:41 UTC
Previous filing
22 Jul 2024
Next filing
01 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Options Exercise $48,750 +121,875 +2.4% $0.4000 5,300,220 15 Nov 2024 Direct
transaction AURX Common Stock Options Exercise $25,000 +62,500 +1.2% $0.4000 5,362,720 15 Nov 2024 Direct
transaction AURX Common Stock Options Exercise $16,667 +33,334 +0.62% $0.5000 5,396,054 15 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to Purchase Common Stock Options Exercise $0 -121,875 -100% $0.000000 0 09 Aug 2018 Common Stock 121,875 $0.4000 Direct
transaction AURX Option to Purchase Common Stock Options Exercise $0 -62,500 -100% $0.000000 0 31 Dec 2018 Common Stock 62,500 $0.4000 Direct
transaction AURX Option to Purchase Common Stock Options Exercise $0 -33,334 -100% $0.000000 0 04 Mar 2022 Common Stock 33,334 $0.5000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.